Cargando…
Novel Bivalent (99m)Tc-Complex with N-Methyl-Substituted Hydroxamamide as Probe for Imaging of Cerebral Amyloid Angiopathy
Cerebral amyloid angiopathy (CAA) is characterized by the deposition of amyloid aggregates in the walls of the cerebral vasculature. Recently, the development of molecular imaging probes targeting CAA has been attracting much attention. We previously reported the (99m)Tc-hydroxamamide ((99m)Tc-Ham)...
Autores principales: | Iikuni, Shimpei, Ono, Masahiro, Watanabe, Hiroyuki, Yoshimura, Masashi, Ishibashi-Ueda, Hatsue, Ihara, Masafumi, Saji, Hideo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045186/ https://www.ncbi.nlm.nih.gov/pubmed/27689870 http://dx.doi.org/10.1371/journal.pone.0163969 |
Ejemplares similares
-
Imaging of Cerebral Amyloid Angiopathy with Bivalent (99m)Tc-Hydroxamamide Complexes
por: Iikuni, Shimpei, et al.
Publicado: (2016) -
Development of a hydroxamamide-based bifunctional chelating agent to prepare technetium-99m-labeled bivalent ligand probes
por: Shimizu, Yoichi, et al.
Publicado: (2021) -
Cerebral Amyloid Angiopathy Presenting as Massive Subarachnoid Haemorrhage: A Case Study and Review of Literature
por: Saito, Satoshi, et al.
Publicado: (2020) -
Development of Novel (123)I-Labeled Pyridyl Benzofuran Derivatives for SPECT Imaging of β-Amyloid Plaques in Alzheimer’s Disease
por: Ono, Masahiro, et al.
Publicado: (2013) -
Development of Technetium-99m-Labeled BODIPY-Based Probes Targeting Lipid Droplets Toward the Diagnosis of Hyperlipidemia-Related Diseases
por: Shimizu, Yoichi, et al.
Publicado: (2019)